KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

GoodRx Holdings (GDRX) Net Margin (2019 - 2025)

GoodRx Holdings' Net Margin history spans 7 years, with the latest figure at 2.79% for Q4 2025.

  • For Q4 2025, Net Margin fell 61.0% year-over-year to 2.79%; the TTM value through Dec 2025 reached 3.82%, up 175.0%, while the annual FY2025 figure was 3.82%, 175.0% up from the prior year.
  • Net Margin for Q4 2025 was 2.79% at GoodRx Holdings, up from 0.57% in the prior quarter.
  • Across five years, Net Margin topped out at 30.99% in Q2 2023 and bottomed at 22.28% in Q3 2022.
  • The 5-year median for Net Margin is 0.81% (2021), against an average of 0.47%.
  • The largest annual shift saw Net Margin soared 17554bps in 2021 before it plummeted -2766bps in 2024.
  • A 5-year view of Net Margin shows it stood at 18.72% in 2021, then skyrocketed by 94bps to 1.07% in 2022, then crashed by -1128bps to 13.16% in 2023, then skyrocketed by 126bps to 3.39% in 2024, then fell by -18bps to 2.79% in 2025.
  • Per Business Quant, the three most recent readings for GDRX's Net Margin are 2.79% (Q4 2025), 0.57% (Q3 2025), and 6.32% (Q2 2025).